Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M263,536Revenue $M71,882Net Margin (%)22.4Altman Z-Score5.1
Enterprise Value $M248,889EPS $5.7Operating Margin %27.3Piotroski F-Score6
P/E(ttm)16.6Beneish M-Score-2.6Pre-tax Margin (%)29.0Higher ROA y-yN
Price/Book3.710-y EBITDA Growth Rate %4.3Quick Ratio2.2Cash flow > EarningsY
Price/Sales3.85-y EBITDA Growth Rate %3.5Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow19.8y-y EBITDA Growth Rate %7.9ROA % (ttm)12.2Higher Current Ratio y-yY
Dividend Yield %3.0PEG4.8ROE % (ttm)22.2Less Shares Outstanding y-yY
Payout Ratio %50.0Shares Outstanding M2,773ROIC % (ttm)26.6Gross Margin Increase y-yY

Gurus Latest Trades with JNJ

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
JNJJoel Greenblatt 2015-06-30 Sold Out -0.64%$97.46 - $103.96
($100.15)
$ 95.17-5%Sold Out0
JNJYacktman Focused Fund 2015-06-30 Reduce-0.6%$97.46 - $103.96
($100.15)
$ 95.17-5%Reduce 16.67%2,500,000
JNJDonald Yacktman 2015-06-30 Reduce-0.46%$97.46 - $103.96
($100.15)
$ 95.17-5%Reduce 11.75%7,441,948
JNJYacktman Fund 2015-06-30 Reduce-0.37%$97.46 - $103.96
($100.15)
$ 95.17-5%Reduce 10.26%3,500,000
JNJTweedy Browne 2015-06-30 Reduce-0.37%$97.46 - $103.96
($100.15)
$ 95.17-5%Reduce 3.38%3,918,801
JNJJohn Rogers 2015-06-30 Add0.14%$97.46 - $103.96
($100.15)
$ 95.17-5%Add 19.02%782,026
JNJDavid Dreman 2015-06-30 Buy 0.05%$97.46 - $103.96
($100.15)
$ 95.17-5%New holding6,648
JNJKen Fisher 2015-06-30 Add0.04%$97.46 - $103.96
($100.15)
$ 95.17-5%Add 1.77%10,641,756
JNJJames Barrow 2015-06-30 Reduce-0.01%$97.46 - $103.96
($100.15)
$ 95.17-5%Reduce 0.28%15,632,757
JNJMario Gabelli 2015-06-30 Reduce-0.01%$97.46 - $103.96
($100.15)
$ 95.17-5%Reduce 5.40%315,150
JNJRichard Pzena 2015-06-30 Add$97.46 - $103.96
($100.15)
$ 95.17-5%Add 0.01%1,174,169
JNJFirst Eagle Investment 2015-06-30 Reduce$97.46 - $103.96
($100.15)
$ 95.17-5%Reduce 1.09%1,610,098
JNJDodge & Cox 2015-06-30 Reduce$97.46 - $103.96
($100.15)
$ 95.17-5%Reduce 4.38%38,235
JNJRuane Cunniff 2015-06-30 Add$97.46 - $103.96
($100.15)
$ 95.17-5%Add 1.87%77,357
JNJTweedy Browne 2015-03-31 Reduce-0.23%$98.32 - $106.39
($101.69)
$ 95.17-6%Reduce 2.09%4,055,962
JNJMichael Price 2015-03-31 Reduce-0.13%$98.32 - $106.39
($101.69)
$ 95.17-6%Reduce 28.57%25,000
JNJYacktman Focused Fund 2015-03-31 Reduce-0.11%$98.32 - $106.39
($101.69)
$ 95.17-6%Reduce 3.23%3,000,000
JNJDonald Yacktman 2015-03-31 Reduce-0.08%$98.32 - $106.39
($101.69)
$ 95.17-6%Reduce 2.08%8,432,672
JNJJoel Greenblatt 2015-03-31 Add0.03%$98.32 - $106.39
($101.69)
$ 95.17-6%Add 5.40%833,196
JNJJohn Rogers 2015-03-31 Add0.03%$98.32 - $106.39
($101.69)
$ 95.17-6%Add 3.95%657,074
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

JNJ is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


JNJ: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
PRINCE CHARLESDirector 2015-08-06Buy2,500$99.25-4.11view
PRINCE CHARLESDirector 2015-06-02Buy2,500$99.22-4.08view
Stoffels PaulusChief Scientific Officer 2015-04-28Sell187,250$100.73-5.52view
Fasolo PeterVP, Global Human Resources 2015-03-05Sell115,307$102.4-7.06view
COSGROVE STEPHEN JCorporate Controller 2014-11-05Sell2,490$108.55-12.33view
Ullmann Michael HVP, General Counsel 2014-10-31Sell17,350$107.43-11.41view
CULLEN JAMESDirector 2014-09-10Sell2,446$104.12-8.6view
Caruso Dominic JVP, Finance; CFO 2014-08-21Sell30,000$104.3-8.75view
COSGROVE STEPHEN JCorporate Controller 2014-05-05Sell22,000$100.05-4.88view
Fasolo PeterVP, Global Human Resources 2014-03-14Sell6,824$93.152.17view

Press Releases about JNJ :

Quarterly/Annual Reports about JNJ:

    News about JNJ:

    Articles On GuruFocus.com
    Five High-Quality Dividend Growth Stocks That Look Very Appealing After Recent Volatility Aug 27 2015 
    AptarGroup: The Leader in Dispensing Innovation Aug 21 2015 
    Valeant Pharmaceuticals' New Female Drug Aug 20 2015 
    JNJ – Should It Be In Your Portfolio? Aug 19 2015 
    AbbVie: The Riskiest Dividend Aristocrat Aug 18 2015 
    focused portfolio Aug 18 2015 
    Long-Term Study: Relative Historical Yield & High Quality Businesses Aug 15 2015 
    Tweedy Browne Reduces 33 Stakes in Portfolio Aug 10 2015 
    20 Dividend Growth Stocks to buy Today for Your Retirement Portfolios: Part 1 Aug 07 2015 
    Johnson & Johnson: 53 Years of Low Risk Dividend Growth Aug 06 2015 

    More From Other Websites
    The 4 Stocks That Held Down the DJIA on Friday Aug 28 2015
    Stocks near session lows Aug 28 2015
    Johnson & Johnson to Participate in the 2015 Wells Fargo 10th Annual Healthcare Conference Aug 28 2015
    Dow 30 Stock Roundup: 3M Lowers 2015 Earnings Outlook, JNJ Subsidiary Sells Splenda Aug 28 2015
    6 Solid Reasons You Should Invest in U.S. Stocks Now Aug 28 2015
    More Bargain Hunting: Three Places to Find the Fattest Dividends Aug 28 2015
    Johnson & Johnson to Participate in the 2015 Wells Fargo 10th Annual Healthcare Conference Aug 27 2015
    Johnson & Johnson to Participate in the 2015 Wells Fargo 10th Annual Healthcare Conference Aug 27 2015
    Contact lens makers taking fight over price law to court Aug 27 2015
    Contact lens makers taking fight over price law to court Aug 27 2015
    Johnson & Johnson partners with PCH to help health care startups Aug 27 2015
    Bristol-Myers Squibb's success in Tampa was a major draw for Johnson & Johnson Aug 27 2015
    Johnson & Johnson goes to Silicon Valley with new hardware partnership Aug 27 2015
    Tampa wins Johnson & Johnson shared services North American HQ Aug 27 2015
    Things could get pricey if you wear contacts Aug 27 2015
    Johnson & Johnson Earnings Q2, 2015 Aug 27 2015
    Contact lens makers see their day in court Aug 27 2015
    5:13 pm Johnson & Johnson's Janssen announce that data published in the New England Journal of... Aug 26 2015
    J&J to Sell Sugar Substitute Splenda to Heartland Food Aug 26 2015
    The 10 Most Recession-Proof Dividend Aristocrats Aug 26 2015

    Add Notes, Comments

    If you want to ask a question or report a bug, please create a support ticket.

    User Comments

    Gurufocus
    ReplyGurufocus - 1 year ago
    test
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK